INCREASED PLASMA FIBRONECTIN IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:6
|
作者
NISHINARITA, S
YAMAMOTO, M
TAKIZAWA, T
HAYAKAWA, J
KARASAKI, M
SAWADA, S
机构
[1] First Department of Medicine, Nihon University, School of Medicine, Tokyo, Itabashi ku
关键词
Fibronectin; Mononuclear Phagocytic System; Systemic Lupus Erythematosus;
D O I
10.1007/BF02031971
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To add to our knowledge of collagen diseases, plasma fibronectin (FN) in patients with systemic lupus erythematosus (SLE) has been measured, and it was determined that the plasma FN value in those with SLE was 454±36 μg/ml, is significantly higher than the FN value in normal subjects (234±21 μg/ml. Further, the plasma FN value of patients with active SLE was significantly higher (591±46 μg/ml than that of patients with non-active SLE (287±31 μg/ml. The plasma FN value of SLE patients was also seen to be associated with the peripheral blood platelet count and with the dose level of the corticosteroid hormone administered to patients. In active SLE patients, it was similarly found that the plasma FN value had a significant correlation with the peripheral blood lymphocyte count and with the dose level of the corticosteroid hormone given to patients. Since the plasma FN value is known to be high in untreated SLE patients, it was felt that the increase of the FN value in SLE patients is not due to the effect of the corticosteroid but to the disease itself. © 1990 Springer-Verlag.
引用
收藏
页码:214 / 219
页数:6
相关论文
共 50 条
  • [21] TRANSAMINASES INCREASED DURING DANAZOL THERAPY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    VINCENS, M
    ATHEA, N
    DOUGADOS, M
    JUNGERS, P
    THERAPIE, 1984, 39 (05): : 541 - 544
  • [22] METHOTREXATE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    GANSAUGE, S
    BREITBART, A
    RINALDI, N
    VONBAUM, H
    SCHWARZEYWILL, M
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1161 - 1161
  • [23] PREGNANCY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    VARNER, MW
    MEEHAN, RT
    SYROP, CH
    STROTTMANN, MP
    GOPLERUD, CP
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (08) : 1025 - 1040
  • [24] PLASMA-EXCHANGE IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    HABERSETZER, R
    SAMTLEBEN, W
    BLUMENSTEIN, M
    GURLAND, HJ
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1983, 6 : 39 - 41
  • [25] PHOTOSENSITIVITY AND LUPUS-ERYTHEMATOSUS DISCOIDES AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    GRUPER, C
    EISENMANN, D
    DUREPAIRE, MR
    BENSOUSSAN, ML
    SEMAINE DES HOPITAUX, 1976, 52 (22-2): : 1413 - 1413
  • [26] INCREASED MONOCYTE PROCOAGULANT ACTIVITY INDEPENDENT OF THE LUPUS ANTICOAGULANT IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    DEPROST, D
    OLLIVIER, V
    TERNISIEN, C
    CHOLLETMARTIN, S
    THROMBOSIS AND HAEMOSTASIS, 1990, 64 (02) : 216 - 221
  • [27] INCREASED RISK OF NEISSERIAL INFECTIONS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    MITCHELL, SR
    NGUYEN, PQ
    KATZ, P
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1990, 20 (03) : 174 - 184
  • [28] INCREASED HYDRAZINE EXCRETION ASSOCIATED WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    TANAKA, K
    JIMI, S
    KAJIYAMA, K
    NISHIGOURI, S
    KAMEDA, S
    YANASE, T
    YAMAGUCHI, M
    MATSUYAMA, K
    IGUCHI, S
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1982, 22 (01): : 55 - 59
  • [29] SYSTEMIC LUPUS-ERYTHEMATOSUS
    HOCHBERG, MC
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1990, 16 (03) : 617 - 639
  • [30] SYSTEMIC LUPUS-ERYTHEMATOSUS
    BRESNIHAN, B
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1979, 22 (01) : 16 - +